Brief: Alpine Immune Sciences Announces R&D Day To Provide Clinical Updates On ALPN-303 And Davoceticept
30/08/2022 21:52
Aug 30 (Reuters) - Alpine Immune Sciences Inc ALPN.O :
* ALPINE IMMUNE SCIENCES ANNOUNCES RESEARCH AND DEVELOPMENT
DAY TO
PROVIDE CLINICAL UPDATES ON WHOLLY-OWNED PROGRAMS ALPN-303 AND
DAVOCETICEPT
Source text for Eikon: ID:nBw41NMZya
Further company coverage: ALPN.O
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings